T-Cell–Dependent Tumor Activity Article Swipe

View

Tsubasa Watanabe , Simone Gaedicke , Elena Guffart , Elke Firat , Gabriele Niedermann ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.22473734

Supplementary Figure 2

Related Topics

Concepts

Blockade Cancer research CD8 Cytotoxic T cell Radiation therapy Chemistry Medicine Oncology Internal medicine Immunology Receptor Biochemistry Antigen In vitro

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.22473734
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361888067

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361888067

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.22473734

Digital Object Identifier
Title: FigureS2 from Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8<sup>+</sup> T-Cell–Dependent Tumor Activity

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Tsubasa Watanabe, Simone Gaedicke, Elena Guffart, Elke Firat, Gabriele Niedermann

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.22473734

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1078-0432.22473734

Direct OA link when available
Concepts: Blockade, Cancer research, CD8, Cytotoxic T cell, Radiation therapy, Chemistry, Medicine, Oncology, Internal medicine, Immunology, Receptor, Biochemistry, Antigen, In vitro

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361888067
doi	https://doi.org/10.1158/1078-0432.22473734
ids.doi	https://doi.org/10.1158/1078-0432.22473734
ids.openalex	https://openalex.org/W4361888067
fwci	0.0
type	preprint
title	FigureS2 from Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8<sup>+</sup> T-Cell–Dependent Tumor Activity
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10158
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9990000128746033
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2730
topics[0].subfield.display_name	Oncology
topics[0].display_name	Cancer Immunotherapy and Biomarkers
topics[1].id	https://openalex.org/T10580
topics[1].field.id	https://openalex.org/fields/24
topics[1].field.display_name	Immunology and Microbiology
topics[1].score	0.9787999987602234
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/2403
topics[1].subfield.display_name	Immunology
topics[1].display_name	Immunotherapy and Immune Responses
topics[2].id	https://openalex.org/T10782
topics[2].field.id	https://openalex.org/fields/22
topics[2].field.display_name	Engineering
topics[2].score	0.9753999710083008
topics[2].domain.id	https://openalex.org/domains/3
topics[2].domain.display_name	Physical Sciences
topics[2].subfield.id	https://openalex.org/subfields/2204
topics[2].subfield.display_name	Biomedical Engineering
topics[2].display_name	Nanoplatforms for cancer theranostics
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2778468042
concepts[0].level	3
concepts[0].score	0.8711623549461365
concepts[0].wikidata	https://www.wikidata.org/wiki/Q273976
concepts[0].display_name	Blockade
concepts[1].id	https://openalex.org/C502942594
concepts[1].level	1
concepts[1].score	0.5972799062728882
concepts[1].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[1].display_name	Cancer research
concepts[2].id	https://openalex.org/C167672396
concepts[2].level	3
concepts[2].score	0.5381420850753784
concepts[2].wikidata	https://www.wikidata.org/wiki/Q417800
concepts[2].display_name	CD8
concepts[3].id	https://openalex.org/C154317977
concepts[3].level	3
concepts[3].score	0.4675276279449463
concepts[3].wikidata	https://www.wikidata.org/wiki/Q376266
concepts[3].display_name	Cytotoxic T cell
concepts[4].id	https://openalex.org/C509974204
concepts[4].level	2
concepts[4].score	0.45367807149887085
concepts[4].wikidata	https://www.wikidata.org/wiki/Q180507
concepts[4].display_name	Radiation therapy
concepts[5].id	https://openalex.org/C185592680
concepts[5].level	0
concepts[5].score	0.377913236618042
concepts[5].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[5].display_name	Chemistry
concepts[6].id	https://openalex.org/C71924100
concepts[6].level	0
concepts[6].score	0.34897810220718384
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[6].display_name	Medicine
concepts[7].id	https://openalex.org/C143998085
concepts[7].level	1
concepts[7].score	0.3427298665046692
concepts[7].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[7].display_name	Oncology
concepts[8].id	https://openalex.org/C126322002
concepts[8].level	1
concepts[8].score	0.2674604654312134
concepts[8].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[8].display_name	Internal medicine
concepts[9].id	https://openalex.org/C203014093
concepts[9].level	1
concepts[9].score	0.15974897146224976
concepts[9].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[9].display_name	Immunology
concepts[10].id	https://openalex.org/C170493617
concepts[10].level	2
concepts[10].score	0.1374862790107727
concepts[10].wikidata	https://www.wikidata.org/wiki/Q208467
concepts[10].display_name	Receptor
concepts[11].id	https://openalex.org/C55493867
concepts[11].level	1
concepts[11].score	0.09398111701011658
concepts[11].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[11].display_name	Biochemistry
concepts[12].id	https://openalex.org/C147483822
concepts[12].level	2
concepts[12].score	0.09106481075286865
concepts[12].wikidata	https://www.wikidata.org/wiki/Q103537
concepts[12].display_name	Antigen
concepts[13].id	https://openalex.org/C202751555
concepts[13].level	2
concepts[13].score	0.05893385410308838
concepts[13].wikidata	https://www.wikidata.org/wiki/Q221681
concepts[13].display_name	In vitro
keywords[0].id	https://openalex.org/keywords/blockade
keywords[0].score	0.8711623549461365
keywords[0].display_name	Blockade
keywords[1].id	https://openalex.org/keywords/cancer-research
keywords[1].score	0.5972799062728882
keywords[1].display_name	Cancer research
keywords[2].id	https://openalex.org/keywords/cd8
keywords[2].score	0.5381420850753784
keywords[2].display_name	CD8
keywords[3].id	https://openalex.org/keywords/cytotoxic-t-cell
keywords[3].score	0.4675276279449463
keywords[3].display_name	Cytotoxic T cell
keywords[4].id	https://openalex.org/keywords/radiation-therapy
keywords[4].score	0.45367807149887085
keywords[4].display_name	Radiation therapy
keywords[5].id	https://openalex.org/keywords/chemistry
keywords[5].score	0.377913236618042
keywords[5].display_name	Chemistry
keywords[6].id	https://openalex.org/keywords/medicine
keywords[6].score	0.34897810220718384
keywords[6].display_name	Medicine
keywords[7].id	https://openalex.org/keywords/oncology
keywords[7].score	0.3427298665046692
keywords[7].display_name	Oncology
keywords[8].id	https://openalex.org/keywords/internal-medicine
keywords[8].score	0.2674604654312134
keywords[8].display_name	Internal medicine
keywords[9].id	https://openalex.org/keywords/immunology
keywords[9].score	0.15974897146224976
keywords[9].display_name	Immunology
keywords[10].id	https://openalex.org/keywords/receptor
keywords[10].score	0.1374862790107727
keywords[10].display_name	Receptor
keywords[11].id	https://openalex.org/keywords/biochemistry
keywords[11].score	0.09398111701011658
keywords[11].display_name	Biochemistry
keywords[12].id	https://openalex.org/keywords/antigen
keywords[12].score	0.09106481075286865
keywords[12].display_name	Antigen
keywords[13].id	https://openalex.org/keywords/in-vitro
keywords[13].score	0.05893385410308838
keywords[13].display_name	In vitro
language	en
locations[0].id	doi:10.1158/1078-0432.22473734
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.22473734
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5022833821
authorships[0].author.orcid	https://orcid.org/0000-0002-2058-335X
authorships[0].author.display_name	Tsubasa Watanabe
authorships[0].author_position	first
authorships[0].raw_author_name	Tsubasa Watanabe
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5077293409
authorships[1].author.orcid	https://orcid.org/0000-0001-7496-4994
authorships[1].author.display_name	Simone Gaedicke
authorships[1].author_position	middle
authorships[1].raw_author_name	Simone Gaedicke
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5084350302
authorships[2].author.orcid	https://orcid.org/0000-0002-7691-8411
authorships[2].author.display_name	Elena Guffart
authorships[2].author_position	middle
authorships[2].raw_author_name	Elena Guffart
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5086398080
authorships[3].author.orcid
authorships[3].author.display_name	Elke Firat
authorships[3].author_position	middle
authorships[3].raw_author_name	Elke Firat
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5081477925
authorships[4].author.orcid	https://orcid.org/0000-0003-1710-0975
authorships[4].author.display_name	Gabriele Niedermann
authorships[4].author_position	last
authorships[4].raw_author_name	Gabriele Niedermann
authorships[4].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1078-0432.22473734
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	FigureS2 from Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8<sup>+</sup> T-Cell–Dependent Tumor Activity
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10158
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9990000128746033
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2730
primary_topic.subfield.display_name	Oncology
primary_topic.display_name	Cancer Immunotherapy and Biomarkers
related_works	https://openalex.org/W1937493075, https://openalex.org/W2414729062, https://openalex.org/W1497833379, https://openalex.org/W1964266791, https://openalex.org/W2402467954, https://openalex.org/W4313313459, https://openalex.org/W2040631670, https://openalex.org/W2049624095, https://openalex.org/W2794323030, https://openalex.org/W2004466917
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1078-0432.22473734
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.22473734
primary_location.id	doi:10.1158/1078-0432.22473734
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.22473734
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.Figure	1
abstract_inverted_index.2</p>	2
abstract_inverted_index.<p>Supplementary	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	5
citation_normalized_percentile.value	0.12658189
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False